INTC
36
-5
PH
77
3
FOX
33
-6
SRE
52
2
AON
23
-9
KEY
50
11
UA
33
3
HST
49
-3
LLY
56
2
LMT
55
-5
GS
78
2
GIS
61
-2
AKAM
45
2
CINF
41
-9
SJM
33
9
AMT
41
-4
ZBH
48
-2
LNC
43
-2
GPS
52
3
PEP
50
-13
INTC
36
-5
PH
77
3
FOX
33
-6
SRE
52
2
AON
23
-9
KEY
50
11
UA
33
3
HST
49
-3
LLY
56
2
LMT
55
-5
GS
78
2
GIS
61
-2
AKAM
45
2
CINF
41
-9
SJM
33
9
AMT
41
-4
ZBH
48
-2
LNC
43
-2
GPS
52
3
PEP
50
-13
Financhill
Back

CytoSorbents 10K Form

Sell
20

CTSO
CytoSorbents

Last Price:
0.81
Seasonality Move:
-6.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q CTSO/CytoSorbents Quarterly
2023-08-01 10Q CTSO/CytoSorbents Quarterly
2023-05-02 10Q CTSO/CytoSorbents Quarterly
2022-11-03 10Q CTSO/CytoSorbents Quarterly
2022-08-02 10Q CTSO/CytoSorbents Quarterly
2022-05-03 10Q CTSO/CytoSorbents Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales: $31.08M
Cash Flow: $-6.54M
Price / Cash Flow: 0
Annual Sales: $0.43
Price / Book: 1.91

Profitability

EPS (TTM): -0.64000
Net Income (TTM): $-28.51M
Gross Margin: $17.13M
Return on Equity: -109.47%
Return on Assets: -52.03%

CytoSorbents Earnings Forecast

Key CytoSorbents Financial Ratios

  • The Gross Profit Margin over the past 16 years for CTSO is 55.10%.
  • The Selling, General & Administrative Expenses for CTSO have been equal to 121.84% of Gross Profit Margin.
  • The Research & Development expenses have been 50.60% of Revenue.
  • The Interest Expense is -15.31% of Operating Income.
  • The Net Earning history of CTSO is -91.71% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

CytoSorbents Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CTSO
CUSIP: 23283X
Website: cytosorbents.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 1.77
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CTSO Technical Analysis vs Fundamental Analysis

Sell
20
CytoSorbents (CTSO) is a Sell

Is CytoSorbents a Buy or a Sell?

  • CytoSorbents stock is rated a Sell
    The current CytoSorbents [CTSO] share price is $0.82. The Score for CTSO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.